NCT03925714View on ClinicalTrials.gov

Impact of P53 and SIRT1 in Type 2 Diabetes

PHASE3RecruitingINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

DM

Interventions

OTHER

life style

life sryle control only

DRUG

Metformin

metformin twice daily

DRUG

Nigetella salivata

NS twice daily

Trial Locations (1)

Unknown

RECRUITING

Sherief Abd-Elsalam, Cairo

All Listed Sponsors

lead

Sherief Abd-Elsalam

OTHER